Skip to main content
Equibles

MARTINGALE ASSET MANAGEMENT L P

Position in COLL — Collegium Pharmaceutical, Inc

CIK 936944 BOSTON, MA
Back to COLL Full portfolio

Position in COLL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,996,611
+$390,931 QoQ
Shares Held
55,155
+13.6% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#76
of 280 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 68% Shared 0% None 32%

Common Shares in COLL Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MARTINGALE ASSET MANAGEMENT L P holds $52,615,067 across 17 Drug Manufacturers - Specialty & Generic names. COLL ranks #11 (3.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 69,799 $11,763,923
2 ALKS
Alkermes plc.
 170,004 $8,908,209
3 AMRX
Amneal Pharmaceuticals, Inc.
 283,033 $4,899,301
4 UTHR
UNITED THERAPEUTICS Corp
 7,622 $4,129,828
5 INDV
Indivior Pharmaceuticals, Inc.
 85,564 $3,510,690
6 SUPN
Supernus Pharmaceuticals, Inc.
 74,348 $3,457,925
7 PCRX
Pacira BioSciences, Inc.
 112,025 $2,842,074
8 ANIP
Ani Pharmaceuticals Inc
 30,741 $2,544,739

All Filings in COLL

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,996,611 55,155
2026-03-31 $1,605,680 48,554
2025-12-31 $1,766,483 38,153
2025-09-30 $1,100,889 31,463
2025-06-30 $384,705 13,010
2024-12-31 $833,342 29,087
2024-09-30 $1,537,369 39,787
2024-06-30 $1,271,771 39,496
2024-03-31 $1,537,116 39,596
2023-12-31 $1,215,471 39,489
2023-09-30 $872,208 39,025
2023-06-30 $830,051 38,625
2023-03-31 $821,033 34,224
2022-12-31 $653,497 28,168
2022-09-30 $389,494 24,313
2022-06-30 $291,068 16,426
2022-03-31 $326,431 16,033
2021-06-30 $236,730 10,014
2021-03-31 $394,131 16,630
2020-12-31 $339,107 16,930
2020-09-30 $1,586,858 76,218
2020-06-30 $547,820 31,304
2020-03-31 $511,733 31,337